Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shannon A Marshall

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Protein Science : a Publication of the Protein Society|July 11, 2006
Simple electrostatic model improves designed protein sequencesEric S Zollars, Shannon A Marshall, Stephen L Mayo
Journal of Molecular Biology|February 7, 2002
Electrostatics significantly affect the stability of designed homeodomain variantsShannon A Marshall, Chantal S Morgan, Stephen L Mayo
Drug Discovery Today|March 12, 2004
Minimizing the immunogenicity of protein therapeuticsArthur J Chirino, Marie L Ary, Shannon A Marshall
Protein Science : a Publication of the Protein Society|April 2, 2005
One- and two-body decomposable Poisson-Boltzmann methods for protein design calculationsShannon A Marshall, Christina L Vizcarra, Stephen L Mayo
Drug Discovery Today|March 14, 2003
Rational design and engineering of therapeutic proteinsShannon A Marshall, Greg A Lazar, Arthur J Chirino, et al.
Current Opinion in Structural Biology|September 2, 2003
Designing proteins for therapeutic applicationsGreg A Lazar, Shannon A Marshall, Joseph J Plecs, et al.
Journal of Computational Chemistry|December 13, 2007
An improved pairwise decomposable finite-difference Poisson-Boltzmann method for computational protein designChristina L Vizcarra, Naigong Zhang, Shannon A Marshall, et al.
Journal of Molecular Biology|July 10, 2003
NMR and temperature-jump measurements of de novo designed proteins demonstrate rapid folding in the absence of explicit selection for kineticsBlake Gillespie, Dung M Vu, Premal S Shah, et al.
Journal of Autoimmunity|May 21, 2013
B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10/Treg-dependent mechanismsJoseph R Podojil, Linda N Liu, Shannon A Marshall, et al.
Science Translational Medicine|March 29, 2013
Blockade of nonhormonal fibroblast growth factors by FP-1039 inhibits growth of multiple types of cancerThomas C Harding, Li Long, Servando Palencia, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Protein Science : a Publication of the Protein Society|July 11, 2006
Simple electrostatic model improves designed protein sequencesEric S Zollars, Shannon A Marshall, Stephen L Mayo
Journal of Molecular Biology|February 7, 2002
Electrostatics significantly affect the stability of designed homeodomain variantsShannon A Marshall, Chantal S Morgan, Stephen L Mayo
Drug Discovery Today|March 12, 2004
Minimizing the immunogenicity of protein therapeuticsArthur J Chirino, Marie L Ary, Shannon A Marshall
Protein Science : a Publication of the Protein Society|April 2, 2005
One- and two-body decomposable Poisson-Boltzmann methods for protein design calculationsShannon A Marshall, Christina L Vizcarra, Stephen L Mayo
Drug Discovery Today|March 14, 2003
Rational design and engineering of therapeutic proteinsShannon A Marshall, Greg A Lazar, Arthur J Chirino, et al.
Current Opinion in Structural Biology|September 2, 2003
Designing proteins for therapeutic applicationsGreg A Lazar, Shannon A Marshall, Joseph J Plecs, et al.
Journal of Computational Chemistry|December 13, 2007
An improved pairwise decomposable finite-difference Poisson-Boltzmann method for computational protein designChristina L Vizcarra, Naigong Zhang, Shannon A Marshall, et al.
Journal of Molecular Biology|July 10, 2003
NMR and temperature-jump measurements of de novo designed proteins demonstrate rapid folding in the absence of explicit selection for kineticsBlake Gillespie, Dung M Vu, Premal S Shah, et al.
Journal of Autoimmunity|May 21, 2013
B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10/Treg-dependent mechanismsJoseph R Podojil, Linda N Liu, Shannon A Marshall, et al.
Science Translational Medicine|March 29, 2013
Blockade of nonhormonal fibroblast growth factors by FP-1039 inhibits growth of multiple types of cancerThomas C Harding, Li Long, Servando Palencia, et al.
Pageof 1